Drug Discovery for Treatment of Hepatitis C Virus Infection: Targeting the NS3 Protease

Wednesday, April 17, 2013 ( 2:00 pm to 3:00 pm )

Location: Babbio 321

Drug Discovery for Treatment of Hepatitis C Virus Infection: Targeting the NS3 Protease

Steven S. Carroll, Ph.D., Director of Pharmacology
,
Merck Research Laboratories, West Point, PA




For more information please contact:



A. K. Ganguly
, Distinguished Research Professor of Chemistry; Associate Director for Research

McLean 316

Phone: 201.216.5540

aganguly@stevens.edu